129 related articles for article (PubMed ID: 35868149)
21. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.
Rao CG; Chianese D; Doyle GV; Miller MC; Russell T; Sanders RA; Terstappen LW
Int J Oncol; 2005 Jul; 27(1):49-57. PubMed ID: 15942643
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1.
Vorobyeva A; Konovalova E; Xu T; Schulga A; Altai M; Garousi J; Rinne SS; Orlova A; Tolmachev V; Deyev S
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392820
[TBL] [Abstract][Full Text] [Related]
23. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
[TBL] [Abstract][Full Text] [Related]
24. PDGFRβ targeted innovative imaging probe for pancreatic adenocarcinoma detection.
Gao X; Xu H; Ye Z; Chen X; Wang X; Chang Q; Gu Y
Talanta; 2023 Apr; 255():124225. PubMed ID: 36587427
[TBL] [Abstract][Full Text] [Related]
25. Quality of recombinant protein determines the amount of autoreactivity detected against the tumor-associated epithelial cell adhesion molecule antigen: low frequency of antibodies against the natural protein.
Schmetzer O; Moldenhauer G; Riesenberg R; Pires JR; Schlag P; Pezzutto A
J Immunol; 2005 Jan; 174(2):942-52. PubMed ID: 15634917
[TBL] [Abstract][Full Text] [Related]
26. Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1.
Deyev SM; Vorobyeva A; Schulga A; Abouzayed A; Günther T; Garousi J; Konovalova E; Ding H; Gräslund T; Orlova A; Tolmachev V
Int J Biol Macromol; 2020 Feb; 145():216-225. PubMed ID: 31863835
[TBL] [Abstract][Full Text] [Related]
27. Neocarzinostatin, Aptamer Conjugates for Targeting EpCAM-positive Tumor Cells.
Athyala PK; Kanwar JR; Chitipothu S; Kanwar RK; Krishnakumar S; Watson JP; Narayanan J
Anticancer Res; 2017 Jul; 37(7):3615-3629. PubMed ID: 28668853
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic implications of epithelial cell adhesion molecule expression across molecular subtypes of breast carcinoma.
Sundaram S; Christian SD; Krishnakumar R; Ramya R; Ramadoss M; Karunagaran D
J Cancer Res Ther; 2020; 16(6):1354-1359. PubMed ID: 33342796
[TBL] [Abstract][Full Text] [Related]
29. Preclinical Evaluation of CD36-Targeting Antiangiogenic Peptide ABT-510 for Near-Infrared Fluorescence Molecular Imaging of Colorectal Cancer.
Luo P; Zhou K; Li G; Tao T; Tao J; Han RPS; Tu Y
Anal Chem; 2023 May; 95(18):7344-7353. PubMed ID: 37104013
[TBL] [Abstract][Full Text] [Related]
30. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
Tang C; Du Y; Liang Q; Cheng Z; Tian J
Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
[TBL] [Abstract][Full Text] [Related]
31. Engineering of an EpCAM-targeting cyclic peptide to improve the EpCAM-mediated cellular internalization and tumor accumulation of a peptide-fused antibody.
Park SW; Jun SY; Kim JS; Kim YS
Biochem Biophys Res Commun; 2021 Oct; 573():35-41. PubMed ID: 34388452
[TBL] [Abstract][Full Text] [Related]
32. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
[TBL] [Abstract][Full Text] [Related]
33. Wash-free and selective imaging of epithelial cell adhesion molecule (EpCAM) expressing cells with fluorogenic peptide ligands.
K C TB; Suga K; Isoshima T; Aigaki T; Ito Y; Shiba K; Uzawa T
Biochem Biophys Res Commun; 2018 Jun; 500(2):283-287. PubMed ID: 29660346
[TBL] [Abstract][Full Text] [Related]
34. Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells.
Liu X; Yang L; Zhang D; Liu T; Yan Q; Yang X
J Cell Physiol; 2019 Apr; 234(4):4504-4514. PubMed ID: 30246502
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines.
Sterzynska K; Kempisty B; Zawierucha P; Zabel M
Folia Histochem Cytobiol; 2012; 50(4):534-41. PubMed ID: 23264216
[TBL] [Abstract][Full Text] [Related]
37. [Detection and clinical value of epithelial cellular adhesion molecule (EpCAM) mRNA positive circulating tumor cells in metastatic breast cancer].
Yan Y; Cheng JP; Di LJ; Song GH; Ren J
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):275-80. PubMed ID: 22517003
[TBL] [Abstract][Full Text] [Related]
38. Biodistribution and PET Imaging of Labeled Bispecific T Cell-Engaging Antibody Targeting EpCAM.
Warnders FJ; Waaijer SJ; Pool M; Lub-de Hooge MN; Friedrich M; Terwisscha van Scheltinga AG; Deegen P; Stienen SK; Pieslor PC; Cheung HK; Kosterink JG; de Vries EG
J Nucl Med; 2016 May; 57(5):812-7. PubMed ID: 26848172
[TBL] [Abstract][Full Text] [Related]
39. EpCAM expression in breast cancer cells is associated with enhanced bone metastasis formation.
Hiraga T; Ito S; Nakamura H
Int J Cancer; 2016 Apr; 138(7):1698-708. PubMed ID: 26576938
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic implications of EpCAM and Sox2 expression in breast cancer.
Abd El-Maqsoud NM; Abd El-Rehim DM
Clin Breast Cancer; 2014 Feb; 14(1):e1-9. PubMed ID: 24201161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
